Status:
RECRUITING
Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB
Lead Sponsor:
Karolinska Institutet
Conditions:
Autoantibodies
Eligibility:
All Genders
18+ years
Brief Summary
In this study, individuals with autoantibodies against Ro/SSA and La/SSB will be followed with regard to clinical manifestations and immunological parameters to identify immunological changes, environ...
Detailed Description
Autoimmune diseases are a diverse group of conditions characterized by chronic inflammation and tissue damage. In systemic autoimmune diseases such as Sjögren disease and systemic lupus erythematosus ...
Eligibility Criteria
Inclusion
- To be included in the risk group, the following criteria must be met:
- \- At least one instance of testing positive for Ro/SSA or La/SSB, regardless of the method used.
- To be included in the control group, the individual must:
- \- Have no rheumatologic disease and no autoantibodies against Ro/SSA or La/SSB.
Exclusion
- Below 18 years of age
- Inability to consent to their own participation
- Ongoing infection or severe illness where the study physician deems participation in the study not to be in the individuals best interest
- Inability to read and understand Swedish, and therefore unable to complete the forms and questionnaires included in the project
Key Trial Info
Start Date :
February 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2038
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06594861
Start Date
February 9 2024
End Date
December 1 2038
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centrum för reumatologi
Stockholm, Sweden